← Leaderboards
Meena Chandok
Ambay Immune Sensors And Controls, Llc
$454,997
Attributed
$454,997
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$454,997 · 1
By mechanism
N43$454,997 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorAlternative TreatmentBaseBiological MarkersBiological MonitoringBiopsyCancer EtiologyCessation Of LifeCurative TreatmentsDesignDoseEffective TherapyExosomeAdvanced Prostate CancerFailureGene ExpressionHigh RiskImmunotherapyMalignant Neoplasm Of ProstateMalignant NeoplasmsModalityMolecular Targeted TherapiesMonitorNovel Therapeutics
Grant awards (2)
FY20 SBIR PHASE I TOPIC #400 - AMBAY RADI-SENSE: NON-INVASIVE, NOVEL TEST TO MONITOR BIOLOGICAL RESPONSE TO RADIOTHERAPY$55,000
N43 · FY2021 · CA · contact PI
FY20 SBIR PHASE I TOPIC #400 - AMBAY RADI-SENSE: NON-INVASIVE, NOVEL TEST TO MONITOR BIOLOGICAL RESPONSE TO RADIOTHERAPY$399,997
N43 · FY2020 · CA · contact PI